Skip to main content

Biocon gets 3 observations from US health regulator for Malaysia facility

The FDA has set a target action date for its Insulin Glargine application in June 2020

from Companies https://ift.tt/37KyXiZ
via IFTTT

Comments

Popular posts from this blog